Floatz logo

Therapeutic Asset Ratings

2,003 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cetrelimab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cetrelimab
Prostate Neuroendocrine Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Cladribine
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer CenterP2CCC (53)
Cladribine
Chronic Myelogenous Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Cladribine
Philadelphia Chromosome Positive
M.D. Anderson Cancer CenterP2CCC (53)
Cladribine
Chronic Myeloid Leukemia
M.D. Anderson Cancer CenterP2CCC (53)
Clofarabine
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
M.D. Anderson Cancer CenterP2CCC (53)
Clofarabine
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer CenterP2CCC (53)
Clofarabine
High Grade B-Cell Lymphoma
M.D. Anderson Cancer CenterP2CCC (53)
Clofarabine
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
M.D. Anderson Cancer CenterP2CCC (53)
Clofarabine
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
M.D. Anderson Cancer CenterP2CCC (53)
Cobimetinib
BRAF V600 Wild Type
M.D. Anderson Cancer CenterP2CCC (53)
Cobimetinib
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP2CCC (53)
Cobimetinib
Inflammatory Breast Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Copanlisib
Ovarian Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Copanlisib
Recurrent Malignant Solid Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Blood and Image Guided
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
CCND1 Protein Overexpression
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Dedifferentiated Chondrosarcoma
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Edema
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Erythema
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
FCER2 Negative
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Bone Giant Cell Tumor
M.D. Anderson Cancer CenterP2CCC (53)
Cyclophosphamide
Malignancy In Giant Cell Tumor Of Bone
M.D. Anderson Cancer CenterP2CCC (53)
Showing 626 to 650 of 2,003 assets
PreviousPage 26 of 81Next